The Board of GlaxoSmithKline Pharmaceuticals Limited has recommended a final dividend of INR 20 and for the financial year ended 31 March, 2020 on Equity Shares of INR 10/- each, subject to the approval of shareholders at the forthcoming Annual General Meeting. Has fixed 20 July 2020, as the Record Date for determining entitlement of members to final dividend (including Special Dividend) for the financial year ended 31 March, 2020. If the final dividend as recommended by the Board of Directors is approved at the AGM, payment of such dividend, subject to deduction of tax at source, will be made on and after 27 July 2020.